Anthony Bergmann

Anthony Bergmann discloses dealings in Capricor Therapeutics, Inc. to SEC (Form 4). Between 16 March 2016 and 25 June 2026, the trades on record add up to 12 filings.

On the open market, the record shows 1 purchase worth €4,386 and 4 sales worth €1.3M. Sales outweigh purchases by €1.3M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant and 6 option exercises. 2026 to date brings no purchases and 4 sales.

On 29 June 2026 came the latest disclosure, an open-market sale for €644k in Capricor Therapeutics, Inc. The clock since the last published purchase (18 March 2016) now reads 3,872 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.